BIOPTRON Hyperlight decreases the risk of infections and reinforces the immune system:
Infections are a major risk factor in chronic open wounds that negatively affect wound management. BIOPTRON Hyperlight contains blue light, which is very well known for its intrinsic antimicrobial effect, without the addition of exogenous photosensitizers. The regular use of BIOPTRON Hyperlight prevents the development of bacterial infection (Opel et al, 2015). In parallel, Bioptron Hyperlight Therapy increases IL-6, which increases the production of IgM antibodies by B lymphocytes, providing defence against blood-borne pathogens (Fenyo et al., 1992). The secretion of IFN-γ is as well promoted, reinforcing the microbicidal and antiviral action of natural killer cells (Zhevago, 2006).
BIOPTRON Hyperlight diminishes inflammation:
BIOPTRON Hyperlight decreases the production of pro-inflammatory cytokines, such as TNF-α, and increases anti-inflammatory cytokines, such as TGF –β and IL-10, in the irradiated region, reducing locally the inflammation of affected epithelium (Falus et al 2011, Zhevago 2006).
BIOPTRON Hyperlight relieves pain:
Constant and intolerable pain is disabling and devastating in patients with chronic wounds. Pain impairs wound healing and slows down patient recovery. Bioptron Hyperlight Therapy reduces pain by stimulating the production of nitric oxide, which decreases the over-stimulation of somatic peripheral nerves and increases vasodilatation, diminishing in parallel the ischemic pain (Gaspariyan et al., 2005; Samoilova et al., 2008).